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394It is accepted that after AKI cellular regeneration of the proximal tubule occurs from intrinsic tubule cells.
Recently, scattered tubular cells (STCs) were discovered as a novel subpopulation of tubule cells involved in
regeneration. STCs have a distinct morphology, unique protein expression profile resembling that of parietal
epithelial cells, proliferate more than the remaining proximal tubule cells, and are less susceptible to injuries. In
response to AKI, STCs become more numerous, independent of the primary insult (ischemic, acute
obstruction, and so forth). STCs can be detected with the highest sensitivity and manipulated by the parietal
epithelial cell–specific, doxycycline inducible transgenic mouse line PEC-rtTA. In cell fate tracing experiments
it was shown that STCs are not a fixed progenitor population. Rather, STCs arise from any surviving proximal
tubule cell. Thus, the STC phenotype is a transient, graded, and specific transcriptional program facilitating
tubular regeneration. Understanding this program my open new approaches to prevent and/or treat AKI.
Semin Nephrol 34:394-403 C 2014 Elsevier Inc.
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Open access under CC BY-NC-ND license.Acute renal failure can be deﬁned as an abruptdecrease in glomerular ﬁltration with resultantazotemia, in most cases caused by acute
ischemic and/or toxic insults.1 In both cases, the
proximal tubule is the main site of injury, therefore
the term acute tubular necrosis often is used synony-
mously. The mammalian kidney is particularly suscep-
tible to these two kinds of acute kidney injuries (AKIs)
for several reasons. First, the mammalian kidney has
no portal blood supply (unlike the mesonephros in ﬁsh,
amphibians, or reptile-like animals). Because all blood
ﬁrst has to pass through the glomeruli in mammals,
glomerular vasoconstriction may decrease the blood
supply of the entire kidney (eg, in hypovolemia). The
proximal tubule is particularly sensitive to ischemia2
because it relies predominantly on aerobic adenosine
triphosphate production (mitochondrial Krebs cycle)
and it cannot use the ischemic salvage pathway of
glycolysis efﬁciently.3ier Inc.
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Open access under CC BY-NC-ND license.Furthermore, the proximal tubule reabsorbs most of
the ﬁltered substances including toxins, in part by
endocytosis. For example, gentamycin is taken up by
the cubilin-megalin complex and gentamycin toxicity
is increased in a water-retaining kidney (induced by
withholding liquids, salt, or volume depletion).4–6
The subsequent mechanisms for AKI still are con-
troversial. Besides a reduction in glomerular ﬁltration
rate, tubular obstruction likely represents a major
factor.7–9 In brief, after AKI, cellular debris and protein
casts obstruct individual nephrons transiently. Depend-
ing on the severity of AKI, many or just a few tubules
are obstructed, resulting in the transient loss of renal
function. Tubular obstruction may last long enough to
drive the affected nephron into reversible or irreversible
degeneration—similar to tubular degeneration after
unilateral ureteral obstruction. In addition, complex
interactions with cells of the immune system and release
of inﬂammatory mediators likely play a role during the
course of AKI (reviewed by Cantaluppi et al10).
Nevertheless, tubules have a remarkable capacity to
regenerate lost cells, usually within less than a week.
The present article focuses on recent insights into the
mechanisms of epithelial repair and regeneration. In
particular, the role of a recently discovered subpopu-
lation of tubule cells is discussed: scattered tubular
cells (STCs). These cells become abundant in response
to AKI and likely play a major role in the regenerative
process.UNIFORM RESPONSE TO AKI: TRANSITION INTO
THE STC PHENOTYPE
In 2011, a novel subpopulation of proximal tubular
cells was described.11 Because these cells showed a
distinct morphology and were scattered as single cells
among fully differentiated inconspicuous tubular cellsSeminars in Nephrology, Vol 34, No 4, July 2014, pp 394–403
Epithelial repair and regeneration after AKI 395throughout the entire proximal tubule, these cells were
termed scattered tubular cells.
STCs show very characteristic morphologic and
ultrastructural features12,13 (Fig. 1A). They generally
are smaller than fully differentiated tubular cells and
may have different shapes.12 In the normal kidney,
they occur as single cells or, less often, as doublets or
triplets. They are surrounded by fully differentiated
tubular cells, mostly with an abrupt transition. In this
setting, STCs often show a narrow ﬂask-like shape.
Importantly, STCs show a dramatic decrease in mito-
chondria compared with neighboring proximal tubule
cells.12,13
In the normal human kidney, STCs can be detected,
preferentially at the inner turn or along infoldings of
the tubule (eg, along the tubular plicae where the
tubule makes a hairpin turn).11–13 The reason for this
preferential location is controversial. Increased
mechanical forces could push the cells into the STC
phenotype, or a hairpin turn could represent a micro-
niche for a ﬁxed progenitor population. However, this
would imply that no STCs should be expected along
the pars recta of the proximal tubule (ie, the S2 and S3
segment), however, this is not the case.Figure 1. STCs. (A) STCs (arrow) lack a brush border and
STCs express a distinct panel of marker proteins (indica
doxycycline-inducible transgenic PEC-rtTA mouse is cu
manipulate proximal tubule cells with the STC phenotype
PEC-rtTA/LC1/R26R triple transgenic mouse expresses
recombination induced by transient administration of doxy
with histone-enhanced green fluorescent protein during adm
is shown in the right panel. In the glomerulus, PECs are ma
marked. TRE, tet-responsive element; neo, neomycin resist
controlled transactivator. Schematic on the left is modifiedIn contrast to differentiated tubule cells, STCs do
not have a pronounced apical brush border. STCs also
express only very low levels of the classic multitarget
protein endocytic transporter megalin. STCs also lack
the basolateral labyrinth of extensive membrane infold-
ings, which is characteristic for differentiated proximal
tubular cells.13 We have shown previously that the
infoldings of the basolateral membrane extend almost
up to the apical aspect of proximal tubule cells. Filtered
albumin is taken up by differentiated proximal tubular
cells from the primary ﬁltrate and released into the
apical aspects of the basolateral labyrinth from where it
diffuses back into the tubulointerstitial capillaries or
lymphatics.14 Absence of an apical brush border and a
basolateral labyrinth strongly suggests that STCs are
less active endocytically compared with differentiated
proximal tubule cells.
In the regenerative phase after AKI, STCs may
become rather abundant and also mostly acquire shapes
similar to the surrounding tubular cells.13,15
To date, it has not been investigated systematically
which stimuli can push tubule cells into the STC
transcriptional program. We have shown previously
that proteinuria or transient ischemia-reperfusion injurya basolateral labyrinth and contain fewer mitochondria.
ted by the orange color), similar to PECs. (B) The
rrently the most sensitive method to mark and/or
. The transgenic map is shown in the left panel. The
β-galactosidase (β-gal) (blue) irreversibly upon Cre
cycline. The PEC-rtTA/H2B-eGFP mouse loads nuclei
inistration of doxycycline (green). The labeling pattern
rked. In the proximal tubule, scattered tubular cells are
ance cassette; rtTA-M2, improved reverse tetracycline-
with permission from Berger et al.50
K. Berger and M.J. Moeller396(IRI) induce the STC phenotype in mice and that
unilateral ureteral obstruction induces the STC pheno-
type in mice and rats.13,15 The multitude of studies
reporting tubular cell phenotypes similar to STCs
suggests that the STC phenotype can be activated by
a multitude of injuries. For example, kidney injury
molecule-1 (Kim-1), one of the STC marker proteins,
is up-regulated in protein-overload nephropathy, con-
sistent with the notion that nephrotic-range proteinuria
alone can increase the frequency of STCs.16STC PROTEIN EXPRESSION PROFILE: DISTINCT
FROM DIFFERENTIATED TUBULE CELLS, SIMILAR
TO PARIETAL EPITHELIAL CELLS
STCs have a very distinct transcriptional proﬁle
compared with fully differentiated proximal tubular
cells.11 In addition, it quickly became obvious that
STCs and parietal epithelial cells (PECs) express
similar markers. This was ﬁrst noted by Lindgren
et al,11 who showed that there are higher levels of
CD133 and CD24 in isolated STCs from human
kidney cortex. In the human kidney, both of these
markers also are expressed by PECs.17 In this context,
it should be noted that only a glycosylation isoform of
CD133 is expressed speciﬁcally on STCs and PECs,
termed glycCD133.18 Furthermore, the glycCD133
isoform is speciﬁc only for STCs and PECs in human
beings, not in rodents. Antibodies directed against total
CD133 show a much more widespread expression in
the kidney (human beings and rodents).
Currently, there are no antibodies available to stain
for CD24 in rodent kidneys. In the rodent kidney, most
other described STC markers13 can be used to identify
STCs, in particular Src-suppressed C kinase substrate,
annexin A3, or Kim-1.15 The parietal epithelial cell–
speciﬁc transgenic PEC–rtTA mouse speciﬁcally labels
STCs and is the only known mouse model targeting
STCs to date15,19 (Fig. 1B). By using the PEC-rtTA
mouse to identify STCs it could be shown that a signal
also transmits induction of the STC phenotype to the
contralateral kidney after unilateral AKI by an as yet
unidentiﬁed soluble mediator. This was ﬁrst reported by
Witzgall et al,20 who showed increased proliferation in
the contralateral kidney after ipsilateral IRI. In our
recent study, increased induction of the STC phenotype
in small but signiﬁcant numbers of proximal tubule
cells in the contralateral kidney was observed during
the recovery phase after unilateral ischemic AKI.15 The
STCs in the contralateral kidney showed increased
proliferation, validating their identity. They could be
identiﬁed only by the PEC-rtTA mouse; other STC
marker detection remained negative. This shows three
major ﬁndings. First, the STC transcriptional program
is graded. Early indicators for the STC phenotype areincreased proliferation and transcriptional activity of the
PEC-rtTA transgenic mouse. Kim-1 already
is up-regulated in microalbuminuric diabetic patients,
suggesting that Kim-1 also may be a relatively early
marker for the STC phenotype.21 Other markers (CD44,
SSeCKS, vimentin, and so forth) are up-regulated in
tubule cells with signiﬁcant activation of the STC
transcriptional program. Second, the PEC-rtTA mouse
is currently the most sensitive method to identify STCs
in proximal tubules in mice. Third, these observations
also provide evidence that a signal is transmitted to the
contralateral kidney, inducing the STC phenotype after
unilateral AKI, most likely by a soluble mediator.
Lindgren et al11 determined the gene expression
proﬁle from total RNA obtained from cortical single-
cell suspensions from human tumor nephrectomies
based on aldehyde dehydrogenase (ALDH) enzymatic
activity, which speciﬁcally is up-regulated in STCs. For
preparation of single cells, kidney tissues were incubated
overnight at 371C in collagenase IV. Decapsulated
glomeruli were removed by sieving. Next, cells were
ﬂuorescence-activated cell-sorted according to ALDH
enzymatic activity. Thus, the ALDHhigh cells (putative
STC proximal tubule cells) also may have contained
PECs. ALDHlow cells comprised all remaining cortical
cells. Transcriptomes were determined using HumanHT-
12 v3.0 Expression Bead Chips (Illumina Inc, San
Diego, CA) and deposited under GSE23911 at the
National Center for Biotechnology Information Gene
Expression Omnibus database. Overall, signiﬁcant dif-
ferences in gene expression proﬁles were noted between
ALDHhigh cells (putative STCs) and the remaining
cortical ALDHlow cells, emphasizing the profound
changes of the STC phenotype.11 Gene-set enrichment
analysis showed that ALDHlow cells expressed more
genes related to membrane transport and lysosomal
proteins consistent with the primary function of tubular
cells.11 ALDHhigh cells showed down-regulation of
some genes involved in apoptosis and up-regulation of
hypoxic genes nuclear factor kappa B and interleukin-6
response gene signatures.
Unfortunately, ALDH cannot be used for histologic
staining, therefore the exact location of the ALDHhigh
cells could not be determined with certainty (eg, in
PECs, in distal tubules or collecting ducts). Further-
more, 7% of all cortical cells were ALDHhigh, which is
a relatively high fraction in a ‘normal’ kidney.11 These
caveats need to be considered when interpreting the
presently available transcriptional proﬁles.STCs MAY BE MORE SIMILAR TO ACTIVATED PECs
THAN TO QUIESCENT PECs
Activation of PECs may occur by as yet unidentiﬁed
mechanisms in multiple different glomerular pathologies
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sclerosis (reviewed by Shankland et al18). Activated
PECs show increased proliferation, migration, and
matrix production. They can be identiﬁed by speciﬁc
markers, such as de novo expression of CD44.
In immunostainings, we have identiﬁed almost 50
additional proteins that are expressed by both PECs
and STCs.13 The most important are vimentin and
CD106 (vascular cell adhesion molecule-1). Previ-
ously, it was reported that CD106 can be used to
differentiate PECs from STCs,22,23 however, this could
not be conﬁrmed in our hands.13 Kim-1 is expressed at
only very low or even negligible levels in quiescent
PECs.13 However, it is signiﬁcantly up-regulated in
activated PECs.24 The same is true for CD44.15,25 This
implies that the STC phenotype has similarities with
the PEC transcriptional program. Activated PECs may
resemble the STC transcriptional program more than
quiescent PECs.STCs: CELLULAR DEDIFFERENTIATION OR
ACTIVATION OF A SPECIFIC TRANSCRIPTIONAL
PROGRAM?
It is an open question whether the STC phenotype
reﬂects cellular dedifferentiation or an alternative
cellular program that is activated speciﬁcally upon
injury. Assuming that cellular dedifferentiation mimics
the transcriptional program in development, it is more
likely that STCs activate an alternative and speciﬁc
transcriptional program. Most of the major STC marker
proteins are not expressed in proximal tubular cells
during renal development (ie, after the S-shaped stage).
This has been shown in the human kidney for
vimentin,26 CD24,27 and CD44,28 and in the rat for
Kim-1.29 A transgenic mouse line driving Cre expres-
sion under control of the Oct-4 promoter does not label
tubule cells in development.30 Oct-4 is very likely a
marker for the STC phenotype.31 In addition, the PEC-
rtTA transgenic mouse line showed no transcriptional
activity in proximal tubules of juvenile mice.15STCs HAVE AN INCREASED CELLULAR
PROLIFERATION
Several investigators have reported increased prolifer-
ation of STCs. Upon AKI, a subset of tubule cells
co-expressed Kim-1 and vimentin and incorporated
more bromodeoxyuridine (BrdU), indicating increased
proliferation of these cells.29 Primary cultures of
ALDHhigh cells (STCs) attach better in culture and
show an increased colony-forming capacity compared
with ALDHlow cells (ie, the remaining cells from
human kidney cortex).11 In addition, the ALDHhigh cells
formed spheres in culture on Matrigel (BD Bioscience,San Jose, CA), whereas the ALDHlow cells did not.
11
STCs in culture showed a higher proliferative index
compared with the remaining tubular cells.22 In human
kidneys with and without acute tubular necrosis, 70%
to 100% of proliferating Ki-67–positive proximal
tubule cells also expressed CD24.13 In transgenic mice
subjected to AKI, up to 80% of the BrdU-positive cells
were STCs.15WHY STCs CAN BE OBSERVED IN NORMAL HUMAN
KIDNEY BUT ARE VIRTUALLY ABSENT IN NORMAL
MOUSE OR RAT KIDNEY
Given vastly different lifespans in rodents and human
beings, it is not surprising that kidneys of adult human
beings always contain a small fraction of glomeruli
with discrete signs of glomerulosclerosis. Normal
human kidneys tend to originate from patients who
suffered from some kind of disease (eg, tumor neph-
rectomies in older patients or autopsy material from
patients who recently died as a result of a serious
condition). In contrast, normal rodent kidneys usually
are derived from healthy young laboratory animals. As
outlined in this review, any injury, such as low-grade
proteinuria, can induce the STC phenotype. This likely
explains why more STCs can be found in the human
kidney.UNINTENTIONAL DESCRIPTIONS OF STCs IN THE
LITERATURE
In retrospect, STCs may have been described in several
studies, however, their signiﬁcance could not be
determined at that time. Some of them are highlighted
here, although more studies likely have made similar
observations.
The earliest description of a distinct cell type with
similarities to STCs next to fully differentiated tubular
cells was reported in regenerating kidneys 2 weeks
after acute injury, but their signiﬁcance was not noted
at that time.32 Houghton et al33 described two different
types of tubular cell morphologies in more detail after
AKI using transmission electron microscopy. First,
there were ‘apparently residual cells’33 with preserved
microvilli, mitochondria, and prominent ER. Cells of
the second type were ‘apparently residual cells’33
(putative STCs). The latter cells were wider with a
more loosely arranged cytoplasm. There were fewer
mitochondria, only rudimentary or absent microvilli,
and no basal infoldings in these cells.
With the advent of immunohistology, multiple
reports have observed the transition of proximal
tubular cells toward a mesenchymal cell (termed
epithelial to mesenchymal transition), associated
with the expression of mesenchymal cell markers
K. Berger and M.J. Moeller398(eg, vimentin, integrin αV, α-smooth muscle actin),
which also are STC markers. In 1994, Witzgall et al20
noted de novo co-expression of the proliferation marker
proliferating cell nuclear antigen and vimentin in tubule
cells after acute ischemic kidney injury (IRI). As
described earlier, vimentin is a marker of the STC
phenotype. In the study by Witzgall et al,20 vimentin
was expressed by 0% of all tubule cells at 0 hours and
peaked after 24 to 48 hours after IRI in 60% of all cells.
Proliferating cell nuclear antigen, on the other hand, was
up-regulated in up to 80% of tubule cells after 48 hours.
In 2006, Gupta et al31 described “multipotent renal
progenitor cells.” These cells were derived from rat
kidney cortex by prolonged culture. The cells
co-expressed vimentin, CD90 (thy1.1), Pax-2, and
Oct-4, and were negative for other markers of differ-
entiated cells. In vivo, the typical scattered distribution
of STCs was observed in transgenic rats driving
β-galactosidase expression under control of the Oct-4
promoter.
Langworthy et al30 showed indirect evidence that
target proteins of calcineurin (Nuclear factor of acti-
vated T-cells, cytoplasmic (NFATc) proteins) are
expressed in presumptive STCs. An increase in intra-
cellular calcium ions triggers the Ca2þ-dependent
phosphatase calcineurin to dephosphorylate NFATc
proteins, which in turn induces their transport into
the nucleus. Calcineurin inhibitors inhibit dephosphor-
ylation of NFATc. Langworthy et al30 used two trans-
genic mouse lines driving either LacZ or Cre
expression under the control of the NFATc promoter
locus. By this approach, they showed that the NFATc
locus is not signiﬁcantly transcriptionally active under
physiological conditions in developing and adult mice,
supporting that STCs are rare under physiological
conditions.
Second, Langworthy et al30 showed that the NFATc
locus becomes transcriptionally active after toxic (mer-
cury) AKI in scattered proximal tubule cells within the
renal cortex. These cells incorporated BrdU, indicating
increased proliferation. Heterozygous NFATcþ/- mice
showed delayed regeneration after mercury-induced
AKI. Similarly, calcineurin inhibitors delayed regener-
ation after AKI.34STCs: FIXED PROGENITOR CELLS VERSUS A
TRANSIENT PHENOTYPE?
Why is this question important? Unraveling the cellular
mechanism of proximal tubule regeneration is a pre-
requisite for developing speciﬁc therapies. For this
purpose, identiﬁcation of the actual target cell and/or of
the subpopulation of tubule cells mediating cellular
regeneration is of prime importance. In a long
sequence of studies, and with improving methodology(especially the advent of in vivo cell fate tracking), it
has been shown conclusively that cellular regeneration
of injured proximal tubule cells occurs from intrinsic
kidney tubule cells (see review by Humphreys35).
However, there is still some controversy about exactly
how tubular cell regeneration occurs and speciﬁcally
what might be the source of the regenerating cells:
ﬁxed intratubular progenitor cells or any surviving
tubular cell.
In this regard, Fanconi syndrome is of interest.
It comprises the clinical consequences of the loss of
speciﬁc segments of the proximal tubule. It may be
acquired after toxic AKI, especially after chemother-
apy. Because acquired Fanconi syndrome may persist
over a lifetime, it shows that lost segments of the
proximal tubule are not repaired from the remaining
segments of the proximal tubule.36,37 Therefore, either
committed ﬁxed intratubular progenitors for example
in the S1 segment cannot regenerate S2 proximal
tubule cells or surviving S1 tubule cells cannot differ-
entiate into S2 tubule cells. Fanconi syndrome teaches
us that the origin of regenerating proximal tubule cells
already is committed to the affected segment.
STCs, A FIXED PROGENITOR POPULATION?
When STCs were ﬁrst discovered, it was proposed that
they are the most likely candidate cell population to
mediate cellular regeneration after AKI.11,23 Several
observations support this notion: STCs become more
numerous after AKI, they express similar antigens as
hematopoietic stem cells (eg, glyCD133, CD24, and
vimentin), and they show a higher proliferation
index.11,22,38 Gupta et al31 characterized the expression
of marker proteins (eg, Oct-4 and Pax-2) on out-
growing cells from the renal cortex and deﬁned these
cells as “stem cells.” In vitro, the cells showed a
capacity for self-renewal for more than 200 population
doublings without evidence for cellular senescence
(ie, β-galactosidase activity). STCs could be differ-
entiated toward tubule cells but not toward glomerular
visceral epithelial cells, indicating some sort of com-
mitment.22 When injecting STCs into the kidneys of
immunocompromised mice after AKI, renal recovery
was improved and the transplanted cells engrafted into
the kidney. This could not be observed when injecting
the remaining tubule cells.22
STCs ARISE FROM ANY SURVIVING PROXIMAL
TUBULE CELL AFTER AKI
On the other hand, accumulating evidence argues in
favor of STCs as a transient regenerative phenotype or
transcriptional program as a common reaction to
injury. First, STCs are virtually absent in healthy
kidneys of laboratory rats or mice.13,15 If STCs were
Figure 2. Cell fate tracking of differentiated tubule cells.39 Left column: When administering low-dose tamoxifen,
only a few single tubules are marked genetically (red). After AKI and regeneration, marked cells tend to occur in
clusters as a result of clonal expansion of single differentiated tubule cells. Right column: When administering
high-dose tamoxifen, the majority of differentiated tubule cells are marked. If regeneration occurred from a
presumptive unmarked fixed progenitor population, significantly fewer tubule cells should be unmarked after AKI
and regeneration. However, this was not observed in the study by Kusaba et al.39
Epithelial repair and regeneration after AKI 399a ﬁxed progenitor population, they always should be
detectable in minimal numbers in healthy kidneys.
Retrospectively, similar observations were made by
Langworthy et al,30 who showed that the NFATc locus
(as a putative marker for STCs) is not transcriptionally
active under physiological conditions in developing
and adult mice (see earlier).
Recently, two major studies were published back-to-
back investigating the potential existence of a ﬁxed
progenitor cell population in proximal tubules.15,39
Both studies used the current gold standard method-
ology of irreversible genetic tagging and cell fate
tracking, but taking very different approaches. Kusaba
et al39 traced the fate of differentiated tubule cells and
Berger et al15 traced the fate of STCs. In combination,
both studies provided extensive experimental evidence
against a ﬁxed progenitor population in proximal
tubules.
Kusaba et al39 drove the expression of a tamoxifen-
inducible Cre mutant CreERT2 within the endogenous
gene locus of the sodium-dependent inorganic phos-
phate transporter SLC34a1. Previously, it was shown
that this gene is expressed speciﬁcally in the kidneyand within the kidney in differentiated proximal tubule
cells.40 Kusaba et al39 showed that the novel knock-in
mouse was transcriptionally active exclusively in the
differentiated proximal tubule cells of the S1/2 seg-
ment and to a lesser extent also in the proximal part of
the S3 segment, recapitulating the expression pattern of
the endogenous SLC34a1 gene.
Next, the fate of differentiated proximal tubule cells
was traced in two alternative experimental approaches
(Fig. 2). The ﬁrst approach was a ‘clone size expan-
sion’ analysis, in which only a small percentage of
differentiated tubule cells were irreversibly genetically
labeled by administration of only low amounts of
tamoxifen before induction of ischemic AKI. After
the regeneration phase, there were fewer solitary
proximal tubule cells (a decrease by approximately
50%) and instead more clusters of labeled proximal
tubule cells. The clusters typically consisted of 2 to
5 labeled cells, indicating that the parent tubule cell
had undergone on average 1 to 3 cellular divisions
during the regeneration phase. The average number in
clusters correlated with the extent of ischemic injury.
Taken together, the results of these experiments show
Figure 3. Cell fate tracing STCs after AKI.15 Left column: The rare STCs in the normal mouse kidney were labeled
by transient administration of doxycycline. After AKI and regeneration, the frequency of labeled proximal tubule
cells did not increase insignificantly, arguing against the notion that STCs are a fixed progenitor population. Right
column: When administering doxycycline after AKI and the subsequent regeneration phase, significantly more
tubule cells were marked, arguing that any surviving proximal tubule cell may acquire the STC phenotype
after AKI.
K. Berger and M.J. Moeller400that cellular regeneration may occur from differentiated
tubule cells.
Next, the investigators performed a dilution experi-
ment, in which as many differentiated proximal tubule
cells as possible ﬁrst were labeled irreversibly by the
administration of high doses of tamoxifen (Fig. 2). It is
virtually impossible for 100% labeling to be achieved
using transgenic mice. The percentage of labeled cells
before induction of ischemic AKI then was compared
with the percentage after the regeneration phase. The
investigators found no signiﬁcant decrease in labeled
cells and concluded that signiﬁcant regeneration did
not occur from an unlabeled ﬁxed progenitor popula-
tion. This conclusion was somewhat limited by the fact
that the investigators could not entirely rule out that the
SLC34a1-CreERT2 mouse was not transcriptionally
active in a putative ﬁxed intratubular progenitor
population, although this possibility is unlikely.
Finally, the investigators showed up-regulation of
STC marker proteins CD133, CD24, KIM-1, and
vimentin in genetically labeled tubule cells after AKI.
This shows that signiﬁcant amounts of differentiatedtubule cells up-regulate expression of STC markers
after injury.
In the second study from our group, Berger et al15
traced the fate of STCs after AKI (Fig. 3). The inves-
tigators took advantage of the fact that PECs and STCs
have a similar protein expression pattern. Our group
previously generated the ﬁrst and to date still the only
available doxycycline-inducible transgenic PEC-rtTA
mouse line that is transcriptionally active in PECs.19 In
the original description of the PEC-rtTA mouse it already
was noted that individual scattered cells in the proximal
tubule were labeled,19 suggesting that the PEC-rtTA
mouse recapitulates the expression pattern of the speciﬁc
transcriptional program in PECs and STCs. Indeed, it
could be shown that the tubular cells marked by the PEC-
rtTA mouse co-express STC markers (KIM-1, annex-
inA3, SSeCKS, and CD44), proliferate more, and become
more numerous in the recovery phase after different
tubular cell injuries. From these ﬁndings, it was con-
cluded that the PEC-rtTA mouse also marks STCs.
To test whether STCs are ﬁxed progenitor cells,
irreversible genetic labeling was induced before AKI
Epithelial repair and regeneration after AKI 401by administration of doxycycline (Fig. 3). However,
after the recovery phase, no signiﬁcant increase of
labeled cells was observed. This ﬁnding ruled out that
STCs are a ﬁxed progenitor population. When induc-
ing the genetic labeling in the PEC-rtTA mouse during
the recovery after AKI, signiﬁcantly more tubular cells
were labeled. The increase in STCs occurred much too
rapidly (ie, within 24 hours) to be explained by cellular
proliferation from only a few pre-existing ﬁxed pro-
genitor cells. Also, STCs appeared throughout the
cortex as individual scattered cells and not in contin-
uous clusters, which would be expected if single clones
expanded.
Taken together, the results show that STCs are not a
ﬁxed progenitor population and that STCs can arise
from any surviving proximal tubular cell.15THE STC PHENOTYPE IS NOT ACTIVATED IN
TUBULE CELLS IN PHYSIOLOGICAL GROWTH
In previous studies, it already was noticed that under
normal conditions, proximal tubular cells undergo
cellular divisions while remaining fully differentiated.
When normal adult rats received BrdU for 1 week and
were analyzed after another week, BrdU-labeled cells
were fully differentiated (ie, formed a brush border).41
In healthy juvenile growing rats, Vogetseder et al42
showed that cycling tubule cells were fully differ-
entiated similar to noncycling cells during physiolog-
ical growth in young rats.
Kusaba et al39 performed the earlier-described
“clone size expansion” experiments using cell fate
tracking of differentiated tubule cells in healthy juve-
nile mice. They found that physiological cellular
divisions of proximal tubule cells occurred at least in
part also from labeled differentiated proximal tubule
cells. Finally, our group showed that no STCs could be
detected in the kidneys of healthy juvenile mice during
physiological growth using the PEC-rtTA mouse.15STCs MAY RENDER THE KIDNEY MORE RESISTANT
TO INJURY
STCs may be more resistant to ischemia because they
contain signiﬁcantly fewer mitochondria.12,13 This
suggests that STCs may be able to derive their
adenosine triphosphate also from glycolysis, but this
still needs further investigation.
In whole-mount tissue culture of explanted human
kidneys, the consequences of ischemia were investigated
by Hansson et al.12 For up to 72 hours of organ culture,
detaching tubule cells did not show the STC phenotype.
On the other hand, tubule cells with the STC phenotype
remained anchored to the basal membrane (20% of all
tubular cells, while 60% of the STCs survived up to 72hours). In vitro, it was shown that STCs show a higher
resistance to injurious agents compared with all other
differentiated cells.22 In summary, this indicates that the
STC phenotype not only may serve regenerative pur-
poses, it also may be more resistant to injuries.DOES TRANSITIONING INTO THE STC PHENOTYPE
MEDIATE THE EFFECT OF PRECONDITIONING?
Preconditioning is a general phenomenon of increased
stress resistance against injuries in virtually all tissues
and all species examined, especially in AKI (for a
summary of the extensive literature see Wever et al43).
Ischemic preconditioning also renders the kidney
resistant to subsequent ischemic injury of the kidney.44
In early studies, it was noticed that tubule cells become
more resistant to the same kind of injury during the
course of AKI. When administering gentamycin to rats
for prolonged periods of time (40 mg/kg/d), after initial
acute tubular injury, recovery occurred despite continued
administration of gentamycin.6,45,46 The acquired resist-
ance against the toxic effects of gentamycin could be
overcome by doubling the dose,45 or by withholding
liquids from the animals to induce water retention and
urine concentration by the kidneys.6 Gentamycin insen-
sitivity was shown to be reversible and transient45 and
also could be induced by other types of tubular necrosis/
regeneration.47 Taken together, these ﬁndings are con-
sistent with the notion that transient transition into the
STC phenotype is associated with a decrease in endocy-
totic activity (see earlier) and renders the tubule cells
more resistant to gentamycin.
The conditioning stimulus is protective when applied to
the target organ itself (ie, kidney) or to a remote tissue (eg,
transient ischemia to the skeletal muscle of the arm/leg
using a simple tourniquet). The protective mechanism of
preconditioning has not yet been resolved at the cellular or
molecular level, but it involves a soluble factor transported
via the blood. Importantly, the time period between the
conditioning stimulus and AKI appears to be crucial. In
general, the protective effect is greatest when the con-
ditioning stimulus is applied approximately 24 hours
before AKI.43 Transition into the STC phenotype takes
place within a similar time frame. It is tempting to
speculate that the as yet unidentiﬁed soluble factor induces
the proximal tubule cells to acquire the STC phenotype,
rendering the kidney more resistant to stress signals and
ameliorating renal damage.STCs AS THERAPEUTIC TARGET: WHAT MAY BE
GOOD FOR THE TUBULE MAY BE BAD FOR THE
GLOMERULUS AND VICE VERSA
We previously have shown that PECs may become
activated in different glomerular diseases.18,48 In all
Figure 4. Potentially opposing effects of therapeutic interventions
in the glomerulus versus the tubule. Because PECs and STCs
have similar transcriptional programs, similar signaling pathways
are expected to be activated in both cell types. Activation of PECs
is associated with glomerular disease, whereas tubule cells
acquiring the STC phenotype (ie, activation) are associated with
increased resistance against injury and increased regeneration,
and vice versa.
K. Berger and M.J. Moeller402forms of glomerular diseases examined to date, PEC
activation contributed to a loss of renal function and
progressive scarring. In the tubule, however, transition
into the STC phenotype appears to be associated with
increased resistance to injury and tubular regeneration.
Because activated PECs and STCs express a similar
and unique transcriptional proﬁle, it is possible that
pharmacologic interventions may exert opposite effects
in the glomerulus and tubular system. It may be
beneﬁcial to inhibit pharmacologically activated PECs
in crescentic nephritis, in which renal function is lost
rapidly by tubular obstruction from proliferating
PECs.18,48 The same inhibitor, however, might exert
negative effects on tubular cell survival by inhibiting
transition into the STC phenotype. Thus, transiently
obstructed tubules may degenerate faster and may no
longer be able to repair once the therapeutic interven-
tion has induced unblocking of the tubules in the
glomerulus (Fig. 4). To treat or even prevent AKI, a
pharmacologic agent will be required that pushes
tubule cells into the STC phenotype. In the glomerulus,
such an agent may activate PECs, and this may be
sufﬁcient to induce crescentic nephritis.49SUMMARY AND OUTLOOK
The STC phenotype of proximal tubules represents a
transient transcriptional program facilitating regenera-
tion and decreasing the susceptibility against injuries.
The transcriptional program likely represents a speciﬁc
reaction to any kind of cellular injury rather than
simple dedifferentiation. STCs proliferate more, are
less susceptible to injuries, and express speciﬁc
markers de novo (Kim-1, vimentin, SSeCKS, annexin
A3, and so forth). Because Kim-1 is expressed by
STCs, it may be regarded as a marker for kidney
regeneration rather than kidney injury. In the proximaltubule, the transgenic doxycycline-inducible PEC-rtTA
mouse speciﬁcally labels STCs with a higher sensitiv-
ity than any of the known STC markers. Thus, the
PEC-rtTA mouse represents an important novel tool to
speciﬁcally mark or manipulate the STC population at
any desired time point. Targeting the STC subpopula-
tion of proximal tubule cells therapeutically is a
promising novel approach to develop a speciﬁc therapy
for prevention and amelioration of AKI.REFERENCES
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